I really want to encourage providers to have these conversations with your patients. Try to dispel the rumors and the innuendo that’s very prevalent on the internet, try to convince people that these two vaccines are incredibly safe.DHMC Interim Section Chief of Medical Oncology Gary N. Schwartz, MD
Nearly a year into the COVID-19 pandemic, we know that people with pre-existing conditions that suppress the immune system are most at risk for serious and even deadly side effects if they contract the virus. Cancer patients undergoing chemotherapy and radiation treatments are extremely vulnerable to infection, and should not hesitate to get vaccinated against COVID-19 to give themselves the best shot at protection, DHMC Interim Section Chief of Medical Oncology Gary N. Schwartz, MD, told “The Cure Podcast” team of physicians in a recent episode.
Listen to episode 5.5 of “The Cure Podcast” HERE
“There’s really no evidence whatsoever that the COVID-19 vaccine would be unsafe in a patient with cancer,” Schwartz said. “I really want to encourage providers to have these conversations with your patients. Try to dispel the rumors and the innuendo that’s very prevalent on the internet, try to convince people that these two vaccines are incredibly safe, and try to influence them on the importance of being vaccinated, and how devastating a COVID-19 infection can be in a patient with cancer.”
About Dartmouth-Hitchcock Health
Dartmouth-Hitchcock Health (D-HH), New Hampshire’s only academic health system and the state’s largest private employer, serves a population of 1.9 million across northern New England. D-HH provides access to more than 2,000 providers in almost every area of medicine, delivering care at its flagship hospital, Dartmouth-Hitchcock Medical Center (DHMC) in Lebanon, NH. DHMC was named again in 2020 as the #1 hospital in New Hampshire by U.S. News & World Report, and recognized for high performance in 9 clinical specialties and procedures. Dartmouth-Hitchcock Health includes the Norris Cotton Cancer Center, one of only 51 NCI-designated Comprehensive Cancer Centers in the nation; Children's Hospital at Dartmouth-Hitchcock, the state’s only children’s hospital; member hospitals in Lebanon, Keene, and New London, NH, and Windsor, VT, and Visiting Nurse and Hospice for Vermont and New Hampshire; and 24 Dartmouth-Hitchcock clinics that provide ambulatory services across New Hampshire and Vermont. The D-HH system trains nearly 400 residents and fellows annually, and performs world-class research, in partnership with the Geisel School of Medicine at Dartmouth and the White River Junction VA Medical Center in White River Junction, VT.